Ipamorelin is a synthetic growth hormone–releasing peptide (GHRP) supplied as a high-purity lyophilized compound intended exclusively for laboratory research use by qualified professionals. Manufactured under controlled conditions to ensure molecular consistency, analytical reliability, and stability.
For laboratory research use only.
Available concentrations:10 mg
Peptide Type: Synthetic growth hormone–releasing peptide (GHRP)
Peptide Class: Ghrelin receptor (GHS-R1a) agonist analog
Amino Acid Length: Pentapeptide
Structural Type: Linear peptide
Source: Synthetic (laboratory-produced)
Physical Form: Lyophilized powder
Purity: >99% (HPLC)
Ipamorelin is utilized in preclinical and experimental research settings investigating:
Growth hormone secretagogue receptor (GHS-R1a) signaling
Pulsatile growth hormone release mechanisms
Hypothalamic–pituitary axis regulation
Peptide-receptor binding selectivity and signaling specificity
Comparative analysis of GHRP family peptides
Endocrine feedback loop modeling in experimental systems
Ipamorelin has been studied in in vitro and animal models for its role in selective GH-related signaling with minimal off-target endocrine activity compared to earlier GHRP analogs. Research applications focus on mechanistic pathway exploration and receptor-level analysis, not therapeutic use.
Storage Conditions: 2–8 °C, protected from light
Stability: Lyophilized format supports extended stability when stored under recommended conditions
Reconstitution: For laboratory research protocols only, using appropriate sterile laboratory techniques
